We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-12.48%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$1.04B
AUM Growth
+$13.6M
Cap. Flow
+$175M
Cap. Flow %
16.88%
Top 10 Hldgs %
6.41%
Holding
1,241
New
361
Increased
285
Reduced
228
Closed
365

Sector Composition

Rank Sector Weight
1 Healthcare 18.01%
2 Industrials 14.63%
3 Technology 13.41%
4 Consumer Discretionary 11.65%
5 Financials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIX icon
676
WIX.com
WIX
$2.45B
$276K 0.03%
+15,843
New +$354K
MOD icon
677
Modine Manufacturing
MOD
$11B
$273K 0.03%
34,650
-22,730
-40% -$212K
CVG
678
DELISTED
Convergys
CVG
$272K 0.03%
11,777
-72,153
-86% -$1.72M
TGH
679
DELISTED
Textainer Group Holdings limited
TGH
$270K 0.03%
16,375
-107,013
-87% -$2.12M
EVTC icon
680
Evertec
EVTC
$1.94B
$268K 0.03%
+14,836
New +$281K
ENZ
681
DELISTED
Enzo Biochem, Inc.
ENZ
$267K 0.03%
84,367
-323,278
-79% -$981K
SGMO
682
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$265K 0.03%
46,971
+4,660
+11% +$38.4K
CPF icon
683
Central Pacific Financial
CPF
$1.02B
$263K 0.03%
12,525
+511
+4% +$11.3K
UTIW
684
DELISTED
UTI WORLDWIDE INC
UTIW
$263K 0.03%
+57,330
New +$426K
MTSN
685
DELISTED
MATTSON TECHNOLOGY INC
MTSN
$262K 0.03%
112,309
-130,268
-54% -$369K
CLDX icon
686
Celldex Therapeutics
CLDX
$2.79B
$261K 0.03%
+1,651
New +$467K
NCI
687
DELISTED
Navigant Consulting, Inc.
NCI
$260K 0.03%
16,351
-8,811
-35% -$135K
FCS
688
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
$260K 0.03%
+18,503
New +$270K
BIT icon
689
BlackRock Multi-Sector Income Trust
BIT
$696M
$258K 0.02%
+16,400
New +$267K
ALNT icon
690
Allient
ALNT
$1.42B
$257K 0.02%
21,728
-16,245
-43% -$211K
TBRA
691
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$256K 0.02%
26,455
+2,770
+12% +$38.9K
AZTA icon
692
Azenta
AZTA
$1.33B
$254K 0.02%
+21,690
New +$234K
ORIT
693
DELISTED
Oritani Financial Corp. New
ORIT
$253K 0.02%
16,187
-8,184
-34% -$127K
RLH
694
DELISTED
Red Lions Hotel Corporation
RLH
$251K 0.02%
+29,524
New +$243K
PN
695
DELISTED
Patriot National, Inc.
PN
$251K 0.02%
+15,829
New +$266K
GSOL
696
DELISTED
Global Sources Ltd
GSOL
$251K 0.02%
30,241
-16,251
-35% -$128K
PFSI icon
697
PennyMac Financial
PFSI
$4.45B
$248K 0.02%
15,474
+2,252
+17% +$39.1K
OPY icon
698
Oppenheimer Holdings
OPY
$1.2B
$246K 0.02%
+12,287
New +$267K
NVTA
699
DELISTED
Invitae Corporation
NVTA
$246K 0.02%
+34,044
New +$358K
ARDC
700
Are Dynamic Credit Allocation Fund
ARDC
$296M
$245K 0.02%
+17,548
New +$260K

Similar funds

TFS Capital's Q3 2015 Portfolio in Review

As of Q3 2015, TFS Capital held 1,241 positions worth $1.04B, up 1.3% from $1.02B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

TFS Capital deployed $175M of net new capital in Q3 2015, opening 361 new positions and adding to 285 existing holdings. Its largest new stake was Aegion Corp: 384,454 shares worth $6.34M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Merit Medical Systems, an estimated $5.27M trimmed.

  • TFS Capital's largest Q3 2015 buy was Aegion Corp: 384,454 shares worth $6.34M.
  • TFS Capital added most to Pernix Therapeutics Holdings, Inc. in Q3 2015, an estimated $6.17M increase.
  • TFS Capital's biggest Q3 2015 reduction was Merit Medical Systems, cutting an estimated $5.27M.
  • TFS Capital fully exited Natus Medical Inc in Q3 2015, selling an estimated $5.73M.
  • TFS Capital's ten largest holdings make up 6.4% of its $1.04B portfolio in Q3 2015.
  • TFS Capital opened 361 new positions and closed 365 in Q3 2015.
  • TFS Capital's portfolio value rose 1.3% quarter-over-quarter to $1.04B.

Based on TFS Capital's 13F filing for Q3 2015, filed 3 Nov 2015.